Chemoinformaics analysis of luteolin-5-o-beta-d-glucopyranoside
| Molecular Weight | 600.884 | nRot | 12 |
| Heavy Atom Molecular Weight | 544.436 | nRig | 3 |
| Exact Molecular Weight | 600.418 | nRing | 2 |
| Solubility: LogS | -3.518 | nHRing | 0 |
| Solubility: LogP | 4.837 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 100 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 107.348 |
| nHD | 2 | BPOL | 57.9156 |
| QED | 0.355 |
| Synth | 2.873 |
| Natural Product Likeliness | 1.833 |
| NR-PPAR-gamma | 0.914 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.026 |
| HIA | 0.063 |
| CACO-2 | -5.029 |
| MDCK | 0.0000343 |
| BBB | 0.43 |
| PPB | 0.97111 |
| VDSS | 0.435 |
| FU | 0.0174879 |
| CYP1A2-inh | 0.07 |
| CYP1A2-sub | 0.306 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.681 |
| CYP2c9-inh | 0.104 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.216 |
| CYP3a4-inh | 0.039 |
| CYP3a4-sub | 0.044 |
| CL | 2.603 |
| T12 | 0.806 |
| hERG | 0.068 |
| Ames | 0.021 |
| ROA | 0.21 |
| SkinSen | 0.971 |
| Carcinogencity | 0.31 |
| EI | 0.61 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.567 |
| Antiviral | Yes |
| Prediction | 0.649409 |